Cannabinol (cbn) + Glofitamab-gxbm
Glofitamab-gxbm brand name: Columvi.
Glofitamab-gxbm falls into 2 drug categories that Cannabinol (cbn) can interact with; the most serious is rated moderate. Theoretically, CYP3A4 inhibitors might increase the levels and clinical effects of cannabinol.
Read the full interaction reportCannabinol (cbn) and Glofitamab-gxbm
These two interact in 2 distinct ways. Each one is explained separately below.
Why Are There 2 Interactions?
Cannabinol (cbn) interacts with whole categories of medication. Glofitamab-gxbm falls into 2 of those categories, so it can interact with Cannabinol (cbn) in 2 different ways. We’ve listed each one below — your overall risk is driven by the most serious of them (Moderate).
CYTOCHROME P450 3A4 (CYP3A4) INHIBITORS
1 of 2Why this applies to Glofitamab-gxbm
Glofitamab-gxbm falls under CYTOCHROME P450 3A4 (CYP3A4) INHIBITORS — the group Cannabinol (cbn) interacts with.
In vitro research shows that CYP3A4 enzymes are involved in the 8-hydroxylation of cannabinol. So far, this interaction has not been reported in humans.
Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
Here's the good news about this pairing: it's really about how your body handles the CBN, not the cancer drug. Glofitamab (Columvi) is a lab-made antibody that helps your immune system attack lymphoma cells. Antibodies like this aren't broken down by liver enzymes such as CYP3A4, so glofitamab won't build up or weaken because of CBN.
The theory on file runs the other direction. Since CYP3A4 helps clear CBN, a CYP3A4 blocker could let CBN linger a bit longer, possibly meaning more drowsiness or grogginess. But this is only test-tube data and hasn't been seen in people, so I wouldn't lose sleep over it. Still, while you're on cancer treatment, please clear any new supplement with your oncology team first.
- Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I. Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sci. 2007;80(15):1415-9. PubMed
CYTOCHROME P450 2C9 (CYP2C9) INHIBITORS
2 of 2Glofitamab-gxbm also falls under CYTOCHROME P450 2C9 (CYP2C9) INHIBITORS.
In vitro research shows that CYP2C9 enzymes are involved in the 11-hydroxylation of cannabinol. So far, this interaction has not been reported in humans.
Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
Here's the thing to keep in mind with this pairing: the interaction runs in an unusual direction. Glofitamab (Columvi) is a lab-made antibody treatment for lymphoma. It isn't broken down by liver enzymes the way pills are, so it isn't really the drug being affected here. Instead, the concern is that if glofitamab acts as a CYP2C9 blocker, it could slow how your body clears CBN, letting the CBN build up a bit.
If that happened, you might notice more of CBN's own effects, like extra drowsiness or grogginess. But honestly, this is theoretical, based only on lab dish studies, and it hasn't been seen in real patients. Since you're on a serious cancer therapy, please run any CBN or cannabis product past your oncology team first before adding it.
- Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I. Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sci. 2007;80(15):1415-9. PubMed
What These Ratings Mean
Every interaction above is graded three ways — here’s the key to each label.
Clinically significant. Avoid the combination, or use only under close professional supervision.
Usually worth avoiding or managing — may need monitoring, a dose change, or timing apart.
Generally not serious. Be aware of it and mention it to your pharmacist.
- LikelyWell-controlled human studies have demonstrated the likely existence of this interaction.
- ProbableInteraction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
- PossibleInteraction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
- UnlikelyInteraction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
- AHigh-quality meta-analysis (quantitative systematic review).
- BCase-control study.
- CConsensus.
- DAnecdotal evidence.
These ratings are for information only. Never start, stop, or otherwise change your therapy before speaking with your provider.
Cannabinol (cbn) Also Interacts With Other Medications
Cannabinol (cbn) has 388 moderate known drug interactions in our database — the Glofitamab-gxbm one above is among them. If you take anything else, check it against the full list below.
Check Another of Your Medications Against Cannabinol (cbn)
We haven’t checked that one against Cannabinol (cbn) yet — ask our pharmacists directly.
Covers the 2,830 medications we’ve checked against Cannabinol (cbn). Pick one to open its full report.
See Every Supplement That Interacts With Glofitamab-gxbm
This page covers Cannabinol (cbn) only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Glofitamab-gxbm page lists 76 supplements it has a documented interaction with, worst first, each one explained.
The most serious there right now: Active Hexose Correlated Compound (ahcc) (moderate), Adrafinil (moderate), Alfalfa (moderate), American Ginseng (moderate) and Andrographis (moderate).
By severity: 71 moderate · 5 minor.
From our pharmacist’s overview on the Glofitamab-gxbm page
“Glofitamab-gxbm (Columvi), an immunotherapy that treats aggressive B-cell lymphoma by steering your own T cells at the cancer, has a supplement list that calls for attentiveness rather than alarm. None of the 76 ingredients on file carries a major rating; 71 sit at moderate and 5 at minor.”
Reviewed by 2 · Jul 18, 2026
Where Cannabinol (cbn) and Glofitamab-gxbm Sit Against Everything Else
Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.
#689 of 1,452 supplements looked up here in the last 7 days
#1,967 of 2,830 medications looked up here in the last 7 days
Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.
About Cannabinol (cbn)
What is Cannabinol (cbn)?
- Sleep support
- Relaxation
- Pain or discomfort
- Appetite-related concerns
Cannabinol (CBN) is a minor cannabinoid found in the cannabis plant, often marketed as a 'sleep' aid, but solid human research is very limited. Because it comes from cannabis and product quality varies widely, talk with your pharmacist or doctor before trying it, and avoid it during pregnancy and breastfeeding.
Other Drugs & Cannabinol (cbn)
Browse every other medication we’ve checked against Cannabinol (cbn) — both the ones with a known interaction and the ones without. Select any drug for the full detail.
No drugs match “”.
388 interactions
- Diclofenac Sodium ›
- Diltiazem ›
- Nifedipine ›
- Ibuprofen ›
- Metronidazole ›
- Naproxen ›
- Erythromycin ›
- Estradiol ›
- Norethindrone ›
- Verapamil ›
- Fenofibrate ›
- Prednisone ›
- Cyclosporine ›
- Dexamethasone ›
- Glyburide ›
- Bupropion ›
- Ciprofloxacin ›
- Flurbiprofen ›
- Orphenadrine ›
- Phenytoin ›
- Diclofenac Potassium ›
- Formoterol ›
- Indomethacin ›
- Miconazole ›
- Trimipramine ›
- Acetaminophen ›
- Diazepam ›
- Everolimus ›
- Meloxicam ›
- Chloramphenicol ›
- Cimetidine ›
- Erythromycin Ethylsuccinate ›
- Erythromycin Stearate ›
- Isoniazid ›
- Itraconazole ›
- Modafinil ›
- Nicardipine ›
- Omeprazole ›
- Paroxetine ›
- Phenobarbital ›
- Warfarin Sodium ›
- Amiodarone ›
- Aprepitant ›
- Carvedilol ›
- Celecoxib ›
- Clarithromycin ›
- Clomipramine ›
- Danazol ›
- Diclofenac Epolamine ›
- Dronabinol ›
- Fluconazole ›
- Fluoxetine ›
- Fluvastatin ›
- Fosamprenavir ›
- Fosaprepitant ›
- Glipizide ›
- Imipramine ›
- Irbesartan ›
- Lacosamide ›
- Lovastatin ›
Showing 60 of 388 moderate interactions — see all 388 on the Cannabinol (cbn) page.
No interaction 2,441 drugs checked — show the list
We also checked Cannabinol (cbn) against these medications and found no known interaction in our sources. Open any page to confirm.
- Apixaban ›
- Levothyroxine ›
- Amlodipine ›
- Methylphenidate ›
- Abemaciclib ›
- Ivermectin ›
- Testosterone ›
- Aspirin ›
- Rosuvastatin ›
- Escitalopram ›
- Metoprolol ›
- Atorvastatin ›
- Rivaroxaban ›
- Isotretinoin ›
- Tirzepatide ›
- Amlodipine Besylate ›
- Methamphetamine ›
- Docusate ›
- Tadalafil ›
- Hydroxyurea ›
- Valacyclovir ›
- Metformin ›
- Sumatriptan ›
- Semaglutide ›
- Lisdexamfetamine ›
- Amphetamine ›
- Levothyroxine, Liothyronine ›
- Propranolol ›
- Methotrexate ›
- Amoxicillin ›
- Lisinopril ›
- Azithromycin ›
- Bendamustine ›
- Pregabalin ›
- Doxycycline ›
- Gabapentin ›
- Dextroamphetamine ›
- Lamotrigine ›
- Acyclovir ›
- Quetiapine ›
- Clonazepam ›
- Buspirone ›
- Duloxetine ›
- Letrozole ›
- Citalopram ›
- Methylene Blue ›
- Candesartan Cilexetil ›
- Amoxicillin, Clavulanate Potassium ›
- Acetylsalicylic Acid ›
- Bisoprolol ›
- Perindopril Arginine, Amlodipine ›
- Amlodipine Besilate ›
- Insulin Degludec, Liraglutide ›
- Amlodipine Besylate, Benazepril ›
- Calcium Oxybate, Magnesium Oxybate, Potassium Oxybate, Sodium Oxybate ›
- Aluminum Hydroxide, Aspirin, Magnesium Hydroxide ›
- Ezetimibe ›
- Dapsone ›
- Cyclopentolate ›
- Cephalexin ›
Showing the 60 most looked-up of 2,441 medications checked with no known interaction — see the full Cannabinol (cbn) list.
Sources & How We Checked
Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference for vitamins, herbs and supplements — the basis for our interaction data.
- MedlinePlus, U.S. National Library of Medicine — NIH consumer drug information, used for the medication overviews.
- NIH Dietary Supplement Label Database (DSLD) — Official supplement product labels.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Taking Cannabinol (cbn) and Glofitamab-gxbm Together: Common Questions
Can you take Cannabinol (cbn) with Glofitamab-gxbm?
Why are there 2 interactions listed for Cannabinol (cbn) and Glofitamab-gxbm?
How serious is the Cannabinol (cbn) and Glofitamab-gxbm interaction?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Still Have a Question About Glofitamab-gxbm and Cannabinol (cbn)?
Our pharmacists answer your medication & supplement questions — free.
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.